Stockreport

Drugmaker Novo Nordisk warns consumers about counterfeit versions of Ozempic in US [USA TODAY]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF The country's health regulator seized the counterfeit injections on April 9 and is investigating them. Surging demand for Novo's Ozempic, chemically known as semaglut [Read more]